Directory
>
Dennis Wahr
Dennis Wahr
CEO | Nuvaira, Inc.
Minneapolis, Minnesota, United States
Dennis Wahr
Summary
Dr. Dennis Wahr is a seasoned entrepreneur and CEO with a strong background in the medical device industry. Since September 2012, he has led Nuvaira, Inc., focusing on innovative treatments for COPD through targeted lung denervation technology. His entrepreneurial journey includes co-founding successful companies like Lutonix and Velocimed, both of which were acquired by major medical firms. Dr. Wahr's expertise spans across clinical trials, FDA regulations, and strategic planning, having overseen numerous clinical trials that have led to product approvals. He has also held prominent board positions in various medical device companies and has experience in venture capital investments. With a foundation in interventional cardiology, Dr. Wahr combines clinical knowledge with business acumen to drive advancements in medical technology.
Dennis Wahr
Work Experience
CEO at
Nuvaira, Inc.
September 2012 - Present
Chairman Of The Board at
Intact Vascular
August 2012 - September 2020
CEO at
Lutonix
July 2007 - December 2011
CEO at
VELOCIMED ASSESSORIA
January 2001 - July 2005
Dennis Wahr
Education
Albion College, Bachelor Of Arts - Ba
University of California, San Francisco - School of Medicine, Cardiology Fellowship
University of Michigan
Frequently Asked Questions about Dennis Wahr
What is Dennis Wahr email address?
Dennis Wahr's primary email address is *****@nuvaira.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Dennis Wahr work for?
Dennis Wahr is a CEO at Nuvaira, Inc., a company specializing in Medical & hospital equipment.
Where Dennis Wahr graduated from?
Dennis Wahr holds a degree in from Albion College.
How can I directly contact Dennis Wahr?
To contact Dennis Wahr directly, you can use the email address *****@nuvaira.com. Complete contact information is available upon registration with Muraena.
Who is Dennis Wahr?
Dr. Dennis Wahr is a seasoned entrepreneur and CEO with a strong background in the medical device industry. Since September 2012, he has led Nuvaira, Inc., focusing on innovative treatments for COPD through targeted lung denervation technology. His entrepreneurial journey includes co-founding successful companies like Lutonix and Velocimed, both of which were acquired by major medical firms. Dr. Wahr's expertise spans across clinical trials, FDA regulations, and strategic planning, having overseen numerous clinical trials that have led to product approvals. He has also held prominent board positions in various medical device companies and has experience in venture capital investments. With a foundation in interventional cardiology, Dr. Wahr combines clinical knowledge with business acumen to drive advancements in medical technology.
Dennis`s contact details
*****@nuvaira.com
Colleagues
SVP Global Market Development
Chief Financial Officer
Board Observer
Vice President Science, Clinical, and R&D